The government on Wednesday warned of the “potentially devastating long-term impact” of the CCP virus on health as a film about “long COVID” is released as part of its national Hands Space Face campaign.
‘Emotive’ Film
In the “emotive” film about long COVID, two women and two men between the ages of 22 and 48 describe breathlessness on exertion, chest pain, and recurring fever weeks and months after catching the virus, the government said.One of those featured in the film said via the government that it’s a mistake to think being “young and fit” will protect you from long COVID.
Another said she had suffered recurring and “overwhelming” symptoms since catching the virus in March.
A third, a 22-year-old, said she has not been able to work for seven months and fears for her future if she doesn’t fully recover.
Health Secretary Matt Hancock said that “irrespective of the seriousness of the initial symptoms” the virus can have serious “long-term” effects on individual health.
He added that people meeting “in large groups or not social distancing” run the risk of causing a higher incidence of long COVID in the population.
New Study
Meanwhile, the government said, a new study from Kings College Cambridge based on data from the ZOE COVID Symptom Study app has shown that 10 percent of 18- to 49-year-olds who catch the virus may experience long COVID symptoms.Claire Steves, lead scientist of the COVID Symptom Study App, said that findings showed certain groups including older people and women were more likely to suffer from long COVID.
She called for “everyone” to download the app to log their daily health.
The government said figures from the Hands Face Space campaign revealed uncertainty among the population around how long virus symptoms could last.
It also said the campaign had found that around a third of 18- to 34-year-olds didn’t realise you could have the disease—and potentially pass it on—without having symptoms.
Hancock said this showed how key “the three essential behaviours” were to reducing transmission.
The up to 90 volunteers expected to initially take part will be healthy 18- to 30-year-olds who will be paid for their participation, it said.
Vaccines that have “proven to be safe in initial trials” will be used and, if approved by regulators, will begin in January 2021.
Results will be expected in May 2021.
Friends Read Free